Jain Global’s Eledon Pharmaceuticals ELDN Stock Holding History

Jain Global’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-67,212	Closed	-$228K	–	1302
2025 Q1	$228K	Buy	+67,212	New	+$277K	﹤0.01%	793

Other funds holding ELDN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Jain Global's ELDN Position: Q2 2025 in Review

Jain Global sold out of Eledon Pharmaceuticals (ELDN) in Q2 2025, closing a stake of 67,212 shares — an estimated $228K sold.

Jain Global first reported a position in ELDN in Q1 2025 and held it in 1 quarter. The position peaked at $228K in Q1 2025. 85 funds tracked by Wall St. Rank hold ELDN as of Q2 2025.

Jain Global reported no remaining Eledon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Jain Global sold 67,212 Eledon Pharmaceuticals shares in Q2 2025, an estimated $228K.
Jain Global first reported a position in Eledon Pharmaceuticals in Q1 2025 and held it in 1 quarter.
Jain Global's Eledon Pharmaceuticals position peaked at $228K in Q1 2025.
85 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.